PNGS Gargi Fashion Jewellery Fund Raise of ₹10.91 Cr

PNGS Gargi Fashion Jewellery Investor Presentation: Key Takeaways

Q2FY27 revenue Rs 540 Mn (+16.3% YoY), PAT Rs 107 Mn (+4.3%), EBITDA margin 26.1% (-196 bps). H1 revenue +14.2%. Retail-led, asset-light expansion.

PNGS Gargi Fashion Jewellery Q2 FY27 Results: Net Profit ₹10.7 Cr, Up 3.9% YoY

PNGS Gargi Fashion Jewellery Ltd reported revenue from operations of ₹54 Cr (+16.4% YoY) and net profit of ₹10.7 Cr (+3.9% YoY) for Q2 FY27.

Key figure

Net profit ₹10.7 Cr · +3.9% YoY

PNGS Gargi Fashion Jewellery Board Meeting Date

PNGS Gargi Fashion Jewellery Ltd will hold its Board on 28 Oct 2026 to approve Q1 and H1 FY27 results. No financial figures or decisions are reported at this stage.

PNGS Gargi Fashion Jewellery Capacity Expansion

PNGS Gargi opened a new exclusive brand store at Pacific Mall, New Delhi on October 20, 2026. The expansion adds to its retail footprint.

new exclusive brand stores

1 stores

PNGS Gargi Fashion Jewellery Capacity Expansion

PNGS Gargi Fashion Jewellery Ltd has opened a new exclusive brand store at Pacific Mall, Jaipur, Rajasthan.

new retail store

1.0 store

PNGS Gargi Fashion Jewellery Other Announcement

PNGS Gargi Fashion Jewellery Ltd filed its quarterly Regulation 74(5) compliance certificate from its RTA, Bigshare Services Private Limited, for the quarter ended September 30, 2026.

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.

Gujarat Inject (Kerala) Fund Raise of ₹3 Cr

Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.

Value

₹3.00 Cr